Member Info for JimiHendrix

The £3m I mentioned is just a rough guess at how much I think they may need before breaking even, however this doesn’t take in to account further revenue, which should ramp up towards that break even point (expected by end of June 2026).

The 90 day window must be there for a reason too, I imagine they’ll allocate shares in 3 tranches, raising a small amount of funds when they absolutely need to and will have in mind potential NHS commissioning for CYP2C19 POC, further adoption, ME sales etc which will all help extend cash runway.

Crucially though positive news during this 90 day window could multiply the share price allowing them to raise way higher and receive more funds. For instance at 1.5p they could raise £3m from issuing just 200m shares, they’ll get more bang for their buck.

Gloria, if this was me I’d vote FOR simply to help those with much more to lose than £19… many people are investing/trading for their family, or for example to build enough deposit for their first home.

“ You forget that there are PIs who lost do much money that they can't even afford the fees to sell their shares. Eg the pi who invested £5000 and has £19 left. Id vote against all resolutions if that was me. “

For someone who has only a small amount left to lose then to vote against would be selfish imo, as others with holdings worth tens of thousands have a lot more to lose. Although their vote wouldn’t count for much as it’s impact is based on how many shares you hold.

The 90 days window suggests they’ll raise a smaller amount initially, particularly if the share price is low. Then raise more later (within 90 days) which allows time for share price rising news… highly likely we’ll get the implementation guide and toolkit within that window.

Hi JohnHenry, yes it came from their presentation at the end of June… https://youtu.be/MrfHKoBtmPM?si=zUQuC0fv3tH_y4t5

My belief is the majority of the revenue needed to achieve this will come from CYP2C19 NHSE commissioning.

I’ve been buying today at 0.6 as I see no reason for this 23% drop on top of the drop we’ve already seen recently, the market was already expecting a placing after all, and the proposed reorganisation simply enables them to do it.

I always keep some cash free just incase the unexpected happens, so haven’t gone all in but do have a sizeable amount.

For the company to say they expect to be EBITDA positive by mid 2026 they must be expecting considerable recurring revenue to start coming in fairly soon. They must know more than they’re sharing with us - my guess was funding pathway for POC testing but let’s see.

No, what did it contain?

Second thoughts the 90 days window suggests they may raise in smaller tranches. Essentially they run out of cash mid-October but have until 14th December to issue the full 400m shares.

So they could raise £500k after the GM to tide them to mid-November and then an another tranche then at what could be a much higher share price depending on news flow. Sales may push the runway out further by then too.

I think they’ll be looking to raise £3m, to give them 6 months cash until EBITDA positive. If they issue all 400m shares the issue price would need to be 0.75p to give them £3m. I’m expecting the price to be higher than the current panic selling drop, by the time a placing is done.

If the company has been able to show an institutional investor how they will be EBITDA positive in the first half of 2026 then it’s also possible placing shares won’t be flipped until much later when the price is far higher, in other words the risk will be lower than with previous placings and they’ll be happy to hold. With this mind and expected recurring revenue and rollouts etc there’s a chance the placing could be at a premium.

It certainly won’t be at 0.3p.

It’s positive of course as the company is now able to legally raise the funds it needs to bridge them to cash positive. This is a buying opportunity from my perspective.

Incorrect Steve lol…

Genedrive is just changing the paperwork on its shares so it can legally raise cash soon: because the share price fell below the old “par” value (1.5p), each existing share will be split into 1 normal share you still trade plus 99 deferred stubs that are worthless and don’t trade; this simply lowers par to 0.015p and doesn’t change the value or number of your tradable shares by itself.

This 25% drop is madness, just market makers taking advantage of panic sellers, many of whom have not understood the RNS. The RNS should be seen as a positive in terms of at least we know the company can now raise some cash and will survive. I wouldn’t be surprised if the price goes back up to 0.8p ish.

Current market capitalisation of £3.59m, madness considering EBITDA positive expected at some point between Jan - June (that’s £6m a year based on their £500k pm expenditure). If the guide lands soon and includes funding pathway for POC the share price will skyrocket.

Genedrive is changing the paperwork on its shares so it can legally raise cash soon: because the share price fell below the old “par” value (1.5p), each existing share will be split into 1 normal share you still trade plus 99 deferred stubs that are worthless and don’t trade; this simply lowers par to 0.015p and doesn’t change the value or number of your tradable shares by itself. At the same time, the board is asking for permission to issue up to 400 million new shares. They also say cash only lasts to mid-October, so a raise is likely near-term.

This funding was expected and will bridge the gap until meaningful income is received. Remember EBITDA positive expect first half of 2026. Implementation guide and toolkit expected soon and Scottish rollout beginning this month.

Here you this explains it better than I can…

Does “99% deferred” mean 99% of your value is gone?

No. The value was never split across 100 pieces. The entire economic value remains in the single ordinary share you keep per original share; the 99 deferreds are deliberately valueless placeholders to achieve the par-value cut. Market cap and your % ownership are unchanged by the reorg itself (price will still move for normal market reasons, and later dilution from any placing is a separate issue).

You’re misunderstanding the reorganisation.

The reorganisation itself shouldn’t change the economic value of your holding…

• Each existing ordinary share becomes 1 new ordinary share (with the same rights) plus 99 deferred shares that have no economic/voting rights. The number of ordinary shares you hold stays the same, so your % ownership and the company’s market cap are unchanged by the reorg alone. 

• The deferred shares won’t be admitted to trading and are designed to be worthless/cancellable; you may not even see them in your brokerage account.

It simply allows them to fundraise below the current nominal value of 1.5p.

I think that’s complete nonsense.

I would hope the implementation guide arrives before the fundraise, or other positive news. What this reorganisation does is ensures they can raise when they need to in the fairly likely event that the share price is still below 1.5p.

The placing may well be above the current share price, considering the current price is already at a large discount to the pre-reorganised nominal value of 1.5p. ChatGPT gives me 0.8 - 1p as the base case based its analysis of everything.